Malignant tumours after renal transplantation.

A. Tóth, F. Alföldy, J. Járay, M. Hidvégi, F. Perner

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The incidence of malignant tumours in 570 patients with kidney transplants was examined. It was found to be 20-30 times higher than in the average (normal) population. In accordance with the literature, mainly skin cancers were observed, but at variance with these data, the number of lymphoreticular malignancies was small. On the basis of their study, the authors emphasize the oncogenetic effect of immunosuppression. By comparing the conventional (AZA+PRED) and Cyclosporine (CYA+PRED) treatments, they point out that this risk should be taken into consideration even in Cyclosporine therapy which has otherwise a much more favourable effect.

Original languageEnglish
Pages (from-to)211-216
Number of pages6
JournalActa Chirurgica Hungarica
Volume33
Issue number3-4
Publication statusPublished - 1992

Fingerprint

Kidney Transplantation
Cyclosporine
Skin Neoplasms
Immunosuppression
Neoplasms
Transplants
Kidney
Incidence
Therapeutics
Population

ASJC Scopus subject areas

  • Surgery

Cite this

Tóth, A., Alföldy, F., Járay, J., Hidvégi, M., & Perner, F. (1992). Malignant tumours after renal transplantation. Acta Chirurgica Hungarica, 33(3-4), 211-216.

Malignant tumours after renal transplantation. / Tóth, A.; Alföldy, F.; Járay, J.; Hidvégi, M.; Perner, F.

In: Acta Chirurgica Hungarica, Vol. 33, No. 3-4, 1992, p. 211-216.

Research output: Contribution to journalArticle

Tóth, A, Alföldy, F, Járay, J, Hidvégi, M & Perner, F 1992, 'Malignant tumours after renal transplantation.', Acta Chirurgica Hungarica, vol. 33, no. 3-4, pp. 211-216.
Tóth, A. ; Alföldy, F. ; Járay, J. ; Hidvégi, M. ; Perner, F. / Malignant tumours after renal transplantation. In: Acta Chirurgica Hungarica. 1992 ; Vol. 33, No. 3-4. pp. 211-216.
@article{a29e6f34a27e4b659defc7eeea220655,
title = "Malignant tumours after renal transplantation.",
abstract = "The incidence of malignant tumours in 570 patients with kidney transplants was examined. It was found to be 20-30 times higher than in the average (normal) population. In accordance with the literature, mainly skin cancers were observed, but at variance with these data, the number of lymphoreticular malignancies was small. On the basis of their study, the authors emphasize the oncogenetic effect of immunosuppression. By comparing the conventional (AZA+PRED) and Cyclosporine (CYA+PRED) treatments, they point out that this risk should be taken into consideration even in Cyclosporine therapy which has otherwise a much more favourable effect.",
author = "A. T{\'o}th and F. Alf{\"o}ldy and J. J{\'a}ray and M. Hidv{\'e}gi and F. Perner",
year = "1992",
language = "English",
volume = "33",
pages = "211--216",
journal = "Magyar Sebeszet",
issn = "0025-0295",
publisher = "Ifjusagi Lapkiado Vallalat",
number = "3-4",

}

TY - JOUR

T1 - Malignant tumours after renal transplantation.

AU - Tóth, A.

AU - Alföldy, F.

AU - Járay, J.

AU - Hidvégi, M.

AU - Perner, F.

PY - 1992

Y1 - 1992

N2 - The incidence of malignant tumours in 570 patients with kidney transplants was examined. It was found to be 20-30 times higher than in the average (normal) population. In accordance with the literature, mainly skin cancers were observed, but at variance with these data, the number of lymphoreticular malignancies was small. On the basis of their study, the authors emphasize the oncogenetic effect of immunosuppression. By comparing the conventional (AZA+PRED) and Cyclosporine (CYA+PRED) treatments, they point out that this risk should be taken into consideration even in Cyclosporine therapy which has otherwise a much more favourable effect.

AB - The incidence of malignant tumours in 570 patients with kidney transplants was examined. It was found to be 20-30 times higher than in the average (normal) population. In accordance with the literature, mainly skin cancers were observed, but at variance with these data, the number of lymphoreticular malignancies was small. On the basis of their study, the authors emphasize the oncogenetic effect of immunosuppression. By comparing the conventional (AZA+PRED) and Cyclosporine (CYA+PRED) treatments, they point out that this risk should be taken into consideration even in Cyclosporine therapy which has otherwise a much more favourable effect.

UR - http://www.scopus.com/inward/record.url?scp=0027018261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027018261&partnerID=8YFLogxK

M3 - Article

C2 - 1345378

AN - SCOPUS:0027018261

VL - 33

SP - 211

EP - 216

JO - Magyar Sebeszet

JF - Magyar Sebeszet

SN - 0025-0295

IS - 3-4

ER -